EVALUATION OF HOMOGENEITY AND STABILITY OF HBV-DNA SAMPLE BY STANDARDS OF PROFICIENCY TEST ITEMS

Vũ Quang Huy1,2,3,, Trần Thị Mỹ Qui1
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 University Medical Center Ho Chi Minh City
3 Center for Standardization and Quality Control in Medical Laboratory of Ho Chi Minh City

Main Article Content

Abstract

Objectives: Development of a production process for lyophilized HBV DNA samples used in proficiency testing. Evaluation of the homogeneity and stability of HBV DNA lyophilized samples after production. Methods: Experimental research on HBV DNA positive plasma samples, evaluate the homogeneity and stability of lyophilized HBV DNA plasma samples by an average comparison test (Oneway ANOVA) and T-test.  Result: Lyophilized HBV DNA plasma samples with three levels of concentration achieved homogeneity and stability in transporting for 7 days. Samples achieved storage stability at -20°C for up to 150 days, at 2-8°C for 90 days, at 25°C and 37°C for 10 days (p value > 0.05). Conclusion: The procedure of lyophilized HBV DNA sample production has been successfully developed. The homogeneity and stability of produced samples meet the criteria standard of ISO 13528:2015 and ISO guide 35.

Article Details

References

1. Bộ Y tế (2019), Về việc ban hành hướng dẫn chẩn đoán, điều trị bệnh viêm gan vi rút B, trang 127.
2. Vũ Quang Huy (2012), Khảo sát tình hình nhiễm Virus viêm gan B và chỉ số men gan trong cộng đồng tại một số khu vực thành phố Hồ Chí Minh, Tạp chí Y học thực hành (ISSN 1859-1663), TP. Hồ Chí Minh, trang 48-52.
3. Vũ Quang Huy (2017), Quy trình thử nghiệm sản xuất mẫu ngoại kiểm định lượng HBV-DNA, Tạp chí Y Học Tp. Hồ Chí Minh, TP. Hồ Chí Minh, trang 216-222.
4. International Organization for Standardization (2006), ISO Guide 35 Reference materials—general and statistical principles for certification, Geneva.
5. International Organization for Standardization (2015), ISO 13528:2015 Statistical methods for use in proficiency testing by interlaboratory comparisons, Geneva.
6. World Health Organization (2017), Global hepatitis report 2017.
7. World Health Organization (2016), WHO Expert Committee on Biological Standardization Collaborative study to evaluate the proposed WHO 4th International Standard for Hepatitis B Virus (HBV) DNA for Nucleic Acid Amplification Technique (NAT) based assays.
8. LN Wang, Wei Deng, ZY Shen, WX Chen, JM Li (2007) Establishment of the first national standards for nucleic acid amplification technology assay for HBV DNA, Chinese journal of hepatology, pp. 107-110.